Crohn’s & Colitis Professional - Crohn's Colitis Professional

Crohn’s & Colitis Professional Hero

IBD Clinical Hub

Discover up-to-date educational resources to enhance your knowledge of Crohn's disease and ulcerative colitis

Featured

APP Biosimilar Education Video Series Module 1
APP Biosimilar Education Video Series Module 1
Medical Therapy
APP Biosimilar Education Video Series Module 1
Donna Bacchus, PhD, MSN, RN; Juanita Belton, MPH, PA-C
- Donna Bacchus, PhD, MSN, RN
- Juanita Belton, MPH, PA-C
ABC’s of Intestinal Surgery – IBD Pharmacist Symposium
ABC’s of Intestinal Surgery – IBD Pharmacist Symposium
Surgical Therapy
ABC’s of Intestinal Surgery – IBD Pharmacist Symposium
Stefan Holubar, MD, MS
- Stefan Holubar, MD, MS
Achieving Successful Transition of IBD Pediatric Patients to Adult Care
Achieving Successful Transition of IBD Pediatric Patients to Adult Care
Health Maintenance
Achieving Successful Transition of IBD Pediatric Patients to Adult Care

Popular

IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
Practice Resources & Guidelines
IBDPro: Intestinal Ultrasound Educational Webinar for Healthcare Professionals
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
MinuteCE®
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Defining Success in IBD: Treat-to-Target
Defining Success in IBD: Treat-to-Target
MinuteCE®
Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD; Ugo Iroku, MD, MHS
2.00 program credits
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 program credits
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
MinuteCE®
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
Where Conventional IBD Therapies Fall Short
Where Conventional IBD Therapies Fall Short
MinuteCE®
Where Conventional IBD Therapies Fall Short
Ugo Iroku, MD, MHS; Michael Dolinger, MD, MBA
2.00 program credits
- Ugo Iroku, MD, MHS
- Michael Dolinger, MD, MBA
2.00 program credits
MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD; Michael Dolinger, MD, MBA
2.00 credits 13 episodes
- David T. Rubin, MD
- Michael Dolinger, MD, MBA
- Florence Odufalu, MD
- Ugo Iroku, MD, MHS
- Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
2.00 credits 13 episodes
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
MinuteCE®
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Michael Dolinger, MD, MBA; David T. Rubin, MD
2.00 program credits
- Michael Dolinger, MD, MBA
- David T. Rubin, MD
2.00 program credits
The Evolving Role of Small Molecules in IBD Care
The Evolving Role of Small Molecules in IBD Care
MinuteCE®
The Evolving Role of Small Molecules in IBD Care
Florence Odufalu, MD; David T. Rubin, MD
2.00 program credits
- Florence Odufalu, MD
- David T. Rubin, MD
2.00 program credits

Clinical Topics

IBDPro: 2026 IBD Pharmacist Virtual Symposium
IBDPro: 2026 IBD Pharmacist Virtual Symposium
Practice Resources & Guidelines
IBDPro: 2026 IBD Pharmacist Virtual Symposium
Virtual Event
IBD Pro: APP Education Conference
November 07, 2026
Virtual
The Future of IBD Therapy: Expert Perspectives on Biosimilars
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Medical Therapy
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI; Ross M. Maltz, MD
- Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
- Ross M. Maltz, MD
- Melissa Kirkpatrick, PharmD, BCACP
Scripps Conference: New Advances in Inflammatory Bowel Disease
Cancer Surveillance (and Prevention!) in IBD
Scripps Conference: New Advances in Inflammatory Bowel Disease
Cancer Surveillance (and Prevention!) in IBD
Medical Therapy
Scripps Conference: New Advances in Inflammatory Bowel Disease
Cancer Surveillance (and Prevention!) in IBD
Millie D. Long, MD, MPH
- Millie D. Long, MD, MPH